These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice. Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040 [TBL] [Abstract][Full Text] [Related]
5. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice. Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. Fukuda D; Enomoto S; Nagai R; Sata M Biomed Pharmacother; 2009 Dec; 63(10):754-61. PubMed ID: 19304450 [TBL] [Abstract][Full Text] [Related]
8. Periaortic adipose tissue-specific activation of the renin-angiotensin system contributes to atherosclerosis development in uninephrectomized apoE-/- mice. Kawahito H; Yamada H; Irie D; Kato T; Akakabe Y; Kishida S; Takata H; Wakana N; Ogata T; Ikeda K; Ueyama T; Matoba S; Mori Y; Matsubara H Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H667-75. PubMed ID: 23812390 [TBL] [Abstract][Full Text] [Related]
9. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice. Iwai M; Inaba S; Tomono Y; Kanno H; Iwanami J; Mogi M; Horiuchi M Hypertens Res; 2008 Jan; 31(1):161-8. PubMed ID: 18360031 [TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
12. Perivascular Adipose Tissue Angiotensin II Type 1 Receptor Promotes Vascular Inflammation and Aneurysm Formation. Sakaue T; Suzuki J; Hamaguchi M; Suehiro C; Tanino A; Nagao T; Uetani T; Aono J; Nakaoka H; Kurata M; Sakaue T; Okura T; Yasugi T; Izutani H; Higaki J; Ikeda S Hypertension; 2017 Oct; 70(4):780-789. PubMed ID: 28760942 [TBL] [Abstract][Full Text] [Related]
13. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
14. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455 [TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445 [TBL] [Abstract][Full Text] [Related]
16. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434 [TBL] [Abstract][Full Text] [Related]
17. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice. Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077 [TBL] [Abstract][Full Text] [Related]
18. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet. Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831 [TBL] [Abstract][Full Text] [Related]
19. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin ameliorates the development of atherosclerosis in apoE-/- mice. Pan CS; Zhang J; Yu F; Teng X; Cao CQ; Wu W; Tang CS; Qi YF Peptides; 2010 Jun; 31(6):1150-8. PubMed ID: 20332006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]